title: The STOP-ACEi Trial - Apt timing for this long awaited randomised controlled trial - Validation of the syndrome of late-onset renal failure from angiotensin blockade (LORFFAB)?
authors.affiliation: Mayo Clinic College of Medicine, Rochester, MN, USA.|Department of Nephrology, Mayo Clinic Health System, Eau Claire, WI, USA.
authors.forename: Macaulay Amechi Chukwukadibia
authors.initials: MA
authors.lastname: Onuigbo
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000809:Angiotensins / Q000037:antagonists & inhibitors*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D051437:Renal Insufficiency / Q000139:chemically induced*; D013577:Syndrome
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins
keywords: STOP-ACEi Trial; angiotensin II receptor blocker; angiotensin-converting enzyme inhibitor; chronic kidney disease; late-onset renal failure from angiotensin blockade; randomised controlled trial; renal failure